Further in vitro experiments confirmed that ectopic expression of FOXN2 suppressed the proliferation of breast cancer cells, and the inhibition of FOXN2 promoted tumor growth, strongly supporting the tumor suppressor roles. Here, FOXN2 is linked to breast carcinoma.